Global Antimalarial Medication Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 161090
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Pharmaceuticals and Healthcare

Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.

Scope of the Report:

Antimalarial medication are the medicines used to prevent and treat malaria.

The worldwide market for Antimalarial Medication is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Antimalarial Medication in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

GlaxoSmithKline

F. Hoffmann-La Roche

Novartis

Pfizer

Sun Pharmaceutical Industries

Merck

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Plasmodium Falciparum

Plasmodium Malariae

Plasmodium Vivax

Plasmodium Ovale

Market Segment by Applications, can be divided into

Hospital Pharmacy

Retail Pharmacy

E- Commerce

Others

There are 15 Chapters to deeply display the global Antimalarial Medication market.

Chapter 1, to describe Antimalarial Medication Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antimalarial Medication, with sales, revenue, and price of Antimalarial Medication, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antimalarial Medication, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antimalarial Medication market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antimalarial Medication sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Antimalarial Medication Introduction

1.2 Market Analysis by Type

1.2.1 Plasmodium Falciparum

1.2.2 Plasmodium Malariae

1.2.3 Plasmodium Vivax

1.2.4 Plasmodium Ovale

1.3 Market Analysis by Applications

1.3.1 Hospital Pharmacy

1.3.2 Retail Pharmacy

1.3.3 E- Commerce

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GlaxoSmithKline

2.1.1 Business Overview

2.1.2 Antimalarial Medication Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GlaxoSmithKline Antimalarial Medication Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 F. Hoffmann-La Roche

2.2.1 Business Overview

2.2.2 Antimalarial Medication Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Antimalarial Medication Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Antimalarial Medication Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Pfizer

2.4.1 Business Overview

2.4.2 Antimalarial Medication Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Pfizer Antimalarial Medication Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sun Pharmaceutical Industries

2.5.1 Business Overview

2.5.2 Antimalarial Medication Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Merck

2.6.1 Business Overview

2.6.2 Antimalarial Medication Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Merck Antimalarial Medication Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Antimalarial Medication Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Antimalarial Medication Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Antimalarial Medication Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Antimalarial Medication Manufacturer Market Share in 2017

3.3.2 Top 6 Antimalarial Medication Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Antimalarial Medication Market Analysis by Regions

4.1 Global Antimalarial Medication Sales, Revenue and Market Share by Regions

4.1.1 Global Antimalarial Medication Sales and Market Share by Regions (2013-2018)

4.1.2 Global Antimalarial Medication Revenue and Market Share by Regions (2013-2018)

4.2 North America Antimalarial Medication Sales and Growth Rate (2013-2018)

4.3 Europe Antimalarial Medication Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Antimalarial Medication Sales and Growth Rate (2013-2018)

4.5 South America Antimalarial Medication Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Antimalarial Medication Sales and Growth Rate (2013-2018)

5 North America Antimalarial Medication by Countries

5.1 North America Antimalarial Medication Sales, Revenue and Market Share by Countries

5.1.1 North America Antimalarial Medication Sales and Market Share by Countries (2013-2018)

5.1.2 North America Antimalarial Medication Revenue and Market Share by Countries (2013-2018)

5.2 United States Antimalarial Medication Sales and Growth Rate (2013-2018)

5.3 Canada Antimalarial Medication Sales and Growth Rate (2013-2018)

5.4 Mexico Antimalarial Medication Sales and Growth Rate (2013-2018)

6 Europe Antimalarial Medication by Countries

6.1 Europe Antimalarial Medication Sales, Revenue and Market Share by Countries

6.1.1 Europe Antimalarial Medication Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Antimalarial Medication Revenue and Market Share by Countries (2013-2018)

6.2 Germany Antimalarial Medication Sales and Growth Rate (2013-2018)

6.3 UK Antimalarial Medication Sales and Growth Rate (2013-2018)

6.4 France Antimalarial Medication Sales and Growth Rate (2013-2018)

6.5 Russia Antimalarial Medication Sales and Growth Rate (2013-2018)

6.6 Italy Antimalarial Medication Sales and Growth Rate (2013-2018)

7 Asia-Pacific Antimalarial Medication by Countries

7.1 Asia-Pacific Antimalarial Medication Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Antimalarial Medication Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Antimalarial Medication Revenue and Market Share by Countries (2013-2018)

7.2 China Antimalarial Medication Sales and Growth Rate (2013-2018)

7.3 Japan Antimalarial Medication Sales and Growth Rate (2013-2018)

7.4 Korea Antimalarial Medication Sales and Growth Rate (2013-2018)

7.5 India Antimalarial Medication Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Antimalarial Medication Sales and Growth Rate (2013-2018)

8 South America Antimalarial Medication by Countries

8.1 South America Antimalarial Medication Sales, Revenue and Market Share by Countries

8.1.1 South America Antimalarial Medication Sales and Market Share by Countries (2013-2018)

8.1.2 South America Antimalarial Medication Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Antimalarial Medication Sales and Growth Rate (2013-2018)

8.3 Argentina Antimalarial Medication Sales and Growth Rate (2013-2018)

8.4 Colombia Antimalarial Medication Sales and Growth Rate (2013-2018)

9 Middle East and Africa Antimalarial Medication by Countries

9.1 Middle East and Africa Antimalarial Medication Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Antimalarial Medication Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Antimalarial Medication Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Antimalarial Medication Sales and Growth Rate (2013-2018)

9.3 UAE Antimalarial Medication Sales and Growth Rate (2013-2018)

9.4 Egypt Antimalarial Medication Sales and Growth Rate (2013-2018)

9.5 Nigeria Antimalarial Medication Sales and Growth Rate (2013-2018)

9.6 South Africa Antimalarial Medication Sales and Growth Rate (2013-2018)

10 Global Antimalarial Medication Market Segment by Type

10.1 Global Antimalarial Medication Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Antimalarial Medication Sales and Market Share by Type (2013-2018)

10.1.2 Global Antimalarial Medication Revenue and Market Share by Type (2013-2018)

10.2 Plasmodium Falciparum Sales Growth and Price

10.2.1 Global Plasmodium Falciparum Sales Growth (2013-2018)

10.2.2 Global Plasmodium Falciparum Price (2013-2018)

10.3 Plasmodium Malariae Sales Growth and Price

10.3.1 Global Plasmodium Malariae Sales Growth (2013-2018)

10.3.2 Global Plasmodium Malariae Price (2013-2018)

10.4 Plasmodium Vivax Sales Growth and Price

10.4.1 Global Plasmodium Vivax Sales Growth (2013-2018)

10.4.2 Global Plasmodium Vivax Price (2013-2018)

10.5 Plasmodium Ovale Sales Growth and Price

10.5.1 Global Plasmodium Ovale Sales Growth (2013-2018)

10.5.2 Global Plasmodium Ovale Price (2013-2018)

11 Global Antimalarial Medication Market Segment by Application

11.1 Global Antimalarial Medication Sales Market Share by Application (2013-2018)

11.2 Hospital Pharmacy Sales Growth (2013-2018)

11.3 Retail Pharmacy Sales Growth (2013-2018)

11.4 E- Commerce Sales Growth (2013-2018)

11.5 Others Sales Growth (2013-2018)

12 Antimalarial Medication Market Forecast (2018-2023)

12.1 Global Antimalarial Medication Sales, Revenue and Growth Rate (2018-2023)

12.2 Antimalarial Medication Market Forecast by Regions (2018-2023)

12.2.1 North America Antimalarial Medication Market Forecast (2018-2023)

12.2.2 Europe Antimalarial Medication Market Forecast (2018-2023)

12.2.3 Asia-Pacific Antimalarial Medication Market Forecast (2018-2023)

12.2.4 South America Antimalarial Medication Market Forecast (2018-2023)

12.2.5 Middle East and Africa Antimalarial Medication Market Forecast (2018-2023)

12.3 Antimalarial Medication Market Forecast by Type (2018-2023)

12.3.1 Global Antimalarial Medication Sales Forecast by Type (2018-2023)

12.3.2 Global Antimalarial Medication Market Share Forecast by Type (2018-2023)

12.4 Antimalarial Medication Market Forecast by Application (2018-2023)

12.4.1 Global Antimalarial Medication Sales Forecast by Application (2018-2023)

12.4.2 Global Antimalarial Medication Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Antimalarial Medication Picture

Table Product Specifications of Antimalarial Medication

Figure Global Sales Market Share of Antimalarial Medication by Types in 2017<

Please fill the form below, to recieve the report sample


+1